Most people who receive a heart transplant enjoy a high quality of life. Depending on your condition, you may be able to return to many of your daily life activities, such as returning to work, participating in hobbies and sports, and exercise. Discuss with your doctor what activities are appropriate for you.
Some women who have had a heart transplant can become pregnant. However, discuss with your doctor if you're considering having children after your transplant. You'll likely need medication adjustments before becoming pregnant, as some medications can cause pregnancy complications.
Heart transplant recipient survival rates vary based on a number of factors. A 2014 report by the Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients stated that the overall survival rate in the U.S. is about 88 percent after one year and about 75 percent after five years.
What if your new heart fails?
Heart transplants aren't successful for everyone. Your new heart may fail because of organ rejection or because of the development of heart valve disease or coronary artery disease. Should this happen, your doctor may recommend adjusting your medications or in more serious cases, another heart transplant.
In some cases, additional treatment options are limited, and you may choose to stop treatment. Discussions with your heart transplant team, doctor and family should generally address your expectations and preferences for treatment, emergency care and end-of-life care.
Aug. 18, 2016
- What is a heart transplant? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/ht. Accessed April 8, 2016.
- Mancini D. Indications and contraindications for cardiac transplantation. http://www.uptodate.com/home. Accessed April 8, 2016.
- Colvin M, et al. OPTN/SRTR annual data report 2014: Heart. American Journal of Transplantation. 2016;16:115.
- What is a ventricular assist device? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/vad. Accessed April 7, 2016.
- What is a total artificial heart? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/tah. Accessed April 12, 2016.
- Flynn B, et al. Heart and lung transplantation. Current Opinion in Anaesthesiology. 2014;27:153.
- Goldman L, et al., eds. Cardiac transplantation. In: Goldman-Cecil Medicine. 25th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. http://www.clinicalkey.com. Accessed April 7, 2016.
- Pham MX. Prognosis after cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
- Pham MX. Induction and maintenance of immunosuppressive therapy in cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
- Pina IL. Rehabilitation after cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
- McKenna WJ. Treatment of amyloid cardiomyopathy. http://www.uptodate.com/home. Accessed April 1, 2016.
- What are the risks of heart surgery? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/hs/risks. Accessed April 12, 2016.
- Barbara Woodward Lips Patient Education Center. Heart transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
- Partnering with your transplant team: The patient's guide to transplantation. U.S. Department of Health and Human Services. https://optn.transplant.hrsa.gov/learn/patient-education/. Accessed April 12, 2016.
- What every patient needs to know. United Network for Organ Sharing. http://www.transplantliving.org/community/patient-resources/publications/. Accessed April 13, 2016.
- Diet and exercise. United Network for Organ Sharing: Transplant living. http://www.transplantliving.org/after-the-transplant/staying-healthy/diet-and-exercise/. Accessed April 13, 2016.
- Eisen HJ. Prevention and treatment of cardiac allograft vasculopathy. http://www.uptodate.com/home. Accessed April 13, 2016.
- Topilsky Y, et al. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation. 2012;125:708.
- Transplant gives recipient chance to re-establish priorities. Mayovox. August 1988;39:1.
- Heart transplant program to resume in fall of 1986. Mayovox. January 1986;37:1.
- Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 8, 2016.
- Matsuo Y, et al. Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation. The Journal of Heart and Lung Transplantation. 2013;32:784.
- Gertz MA, et al. Pathophysiology and treatment of cardiac amyloidosis. Nature Reviews Cardiology. 2015;12:91.
- Williams BA, et al. Heart failure and heart rhythm disorders. In: Current Diagnosis & Treatment: Geriatrics. 2nd ed. New York, N.Y.: The McGraw-Hill Companies; 2014. http://www.accessmedicine.com. Accessed April 21, 2016.
- Guddetti RR, et al. Clinical implications of intracoronary imaging in cardiac allograft vasculopathy. Circulation: Cardiovascular Imaging. 2015;8:e002636.
- Yancy CW, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62: e147.
- Yip DS (expert opinion). Mayo Clinic, Jacksonville, Fla. May 24, 2016.
- Medical practice report: Heart transplant. Press Ganey. http://www.pressganey.com/. Accessed May 24, 2016.
- Lund LH, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second official adult heart transplantation report — 2015; focus theme: Early graft failure. The Journal of Heart and Lung Transplantation. 2015;34:1244.
- Procedure details
- More about